CDMO Technology Domain
Advanced Formulation — Page 2
State-of-the-art dosage form engineering: polymeric sustained-release matrices, lipid-based drug delivery, enteric-coated capsules, and novel excipient selection.
49
dossiers
Glycolysis-Restricted FSMP (Oncology Nutrition)
Technologies and Ingredients for Glycolysis-Restricted Medical Foods in Oncology Nutrition
Developing glycolysis-restricted Foods for Special Medical Purposes (FSMP) for oncology patients is challenged by cancer cachexia, patient dysgeusia, and the need for advanced solutions in lipid-based formulation and product stability.
Post-GLP-1 Metabolic Optimization
In Vivo Gene Editing via Lipid Nanoparticles: Base Editor Mechanisms and PCSK9 Targeting
Developing safe, durable, and highly targeted in vivo delivery systems for gene editing machinery (e.g., mRNA encoding base editors) to specific tissues like the liver via LNPs remains a significant challenge, requiring precise control over biodistribution and off-target effects.
Catecholamine Homeostasis & Executive Function
Kava (Piper methysticum) in Psychiatry: Clinical Effects, Mechanisms, and Safety Signals with Emphasis on Anxiety Disorders
Developing safe and effective Kava-derived anxiolytics is challenging due to inherent hepatotoxicity concerns and potential herb-drug interactions, necessitating novel formulation strategies to mitigate adverse events while preserving therapeutic efficacy.
Cellular Longevity & Senolytics
Targeted Mitochondrial Medicine: Synergistic Modulation of AMPK and NAD⁺ Salvage Pathways for Cardiometabolic Health
The challenge lies in developing stable, bioavailable, and synergistically effective combination formulations of NAD⁺ precursors and AMPK modulators to precisely target cellular bioenergetic decline in age-related cardiometabolic conditions.
Transmucosal Delivery & Dosage Form Engineering
Nutraceutical Pharmacokinetics: Advanced Delivery Systems for Improved Bioavailability
Many clinically relevant nutraceuticals exhibit poor oral bioavailability due to extensive first-pass metabolism and unfavorable physicochemical properties, making their therapeutic efficacy unpredictable in conventional forms.
Transmucosal Delivery & Dosage Form Engineering
Breakthroughs in Nutraceutical & Functional Food Technology: Delivery Systems, Green Manufacturing, and AI-Driven Precision Nutrition
Developing advanced nutraceuticals is challenged by low ingredient solubility, poor stability, and the lack of targeted or controlled release mechanisms, hindering optimal bioavailability and physiological efficacy. Ensuring robust evidence and regulatory acceptance for novel formulations further complicates development.
Post-GLP-1 Metabolic Optimization
Nutraceutical Toxicology and Herb-Drug Interactions (HDI/NDI): A Clinical Review of Six Critical Pharmacological Mechanisms
Developing safe and effective drug formulations requires comprehensive consideration of potential, often undisclosed, herb-drug interactions that can compromise efficacy or lead to life-threatening toxicities, especially with narrow therapeutic index compounds.
Intracellular Defense & IV-Alternatives
Personalized mRNA Neoantigen Vaccines: Efficacy and Safety in Melanoma and PDAC
Developing personalized mRNA neoantigen vaccines requires rapid, custom manufacturing workflows within a narrow therapeutic window, presenting significant logistical and scale-up complexities for widespread clinical adoption.
Precision Microbiome & Gut-Brain Axis
Pharmacomicrobiomics: Gut Microbiota Modulation of Drug Efficacy and Nutraceutical Biotransformation
Integrating the profound and variable metabolic capacity of the gut microbiome into pharmaceutical development to ensure consistent drug efficacy and bioavailability across diverse patient populations is a significant hurdle.
Transmucosal Delivery & Dosage Form Engineering
Piperine-Mediated Potentiation of Direct Oral Anticoagulants: A Clinically Unrecognized Hemorrhagic Risk
Piperine, marketed as a 'bio-enhancer' in nutraceuticals, dangerously potentiates DOACs by inhibiting P-gp and CYP3A4, leading to critical hemorrhagic risk due to uncontrolled increases in drug exposure. This unrecognized interaction demands safer alternatives for enhancing polyphenol bioavailability.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Quantum Physics and Medicine: A Review of Common Aspects
Integrating quantum phenomena, essential for advanced diagnostics and computation, into stable and functional biomedical devices for precise clinical application amidst complex biological environments presents a significant CDMO hurdle.
Microvascular Hemodynamics & Endothelial Integrity
Common Aspects of Quantum Physics and Phlebology: A Literature Review
Developing precise, wavelength-optimized laser ablation and advanced imaging modalities for phlebology requires deep understanding of photon-tissue interaction and complex quantum phenomena, posing significant engineering and material science hurdles for consistent clinical outcomes.
Transmucosal Delivery & Dosage Form Engineering
Innovations in Softgel Capsule Technology: Shell Materials, Lipid Formulations, and Stability Modeling
Developing advanced softgel formulations to overcome low water solubility and variable bioavailability of drug candidates, while addressing manufacturing, stability, and release challenges associated with novel plant-based shell materials.
Post-GLP-1 Metabolic Optimization
Triple Agonists and Next-Generation Oral GLP-1s: Advancements in Metabolic Disorder Therapeutics
Formulating complex multi-receptor agonists and high-potency oral GLP-1 peptides requires advanced delivery systems to ensure bioavailability, stability, and patient adherence while mitigating gastrointestinal side effects.
Catecholamine Homeostasis & Executive Function
Clinical Nutrigenomics: One-Carbon Metabolism, MTHFR/COMT Polymorphisms, and Unmetabolized Folic Acid Toxicity
Developing stable, bioavailable dosage forms of 5-methyltetrahydrofolate (5-MTHF) that effectively bypass common one-carbon metabolism genetic polymorphisms (e.g., MTHFR, COMT) is critical to prevent unmetabolized folic acid (UMFA) toxicity and ensure optimal folate status. This requires precise formulation to overcome stability issues inherent to reduced folates while ensuring clinical efficacy across genetically diverse populations.
Intracellular Defense & IV-Alternatives
De Novo Generative AI Drug Design: Clinical Progress and Methodological Landscape
Developing novel therapeutic molecules with high specificity and optimized pharmacological profiles rapidly, particularly for challenging targets, requires innovative and efficient design methodologies beyond traditional discovery pipelines.
Transmucosal Delivery & Dosage Form Engineering
Physicochemical Challenges in Alcohol-Free Sublingual Sprays: Solutions for Enhanced Stability and Bioavailability
Formulating stable alcohol-free sublingual sprays presents significant challenges, particularly for complex blends of amino acids and lipophilic botanicals, due to issues like crystallisation, phase separation, and subsequent nozzle obstruction.
Cellular Longevity & Senolytics
BCS Class IV Senolytics: Nano-Micellar Flavonoid Delivery for Targeted Senescence Clearance
Hydrophobic senolytic flavonoids like fisetin and quercetin face significant bioavailability challenges due to poor aqueous solubility, limiting their therapeutic potential. Conventional formulations fail to achieve adequate systemic exposure for effective cellular senescence clearance.
Intracellular Defense & IV-Alternatives
Isomeric Stabilization in High-Moisture Matrices: Protecting Fixed-Ratio Inositol Formulations
Fixed-ratio solid formulations are prone to segregation during manufacturing, especially under moisture-driven property changes, causing dose uniformity and accuracy challenges.
Intracellular Defense & IV-Alternatives
Intrapartum Bioenergetics: Rheological Engineering of a Carbohydrate-Based Hydrogel Matrix to Overcome Delayed Gastric Emptying During Active Labour
Developing a carbohydrate formulation for active labour is challenging due to delayed gastric emptying, high aspiration risk, and the need to prevent maternal and neonatal dysglycemia. Current oral options are inadequate, often necessitating IV administration.
Advanced BBB Permeability Solutions
Lipidic Nanoformulations for BBB Transport of Lipophilic Phytochemicals: Current Evidence and Challenges
Lipophilic phytochemicals exhibit poor systemic and brain bioavailability due to rapid metabolism, low solubility, and active efflux at the blood-brain barrier, impeding clinical translation.
Intracellular Defense & IV-Alternatives
Oxidative Stress Mitigation in Nutraceutical Stability: Packaging and Formulation Strategies
Nutraceutical dosage forms face significant degradation due to oxidative stress, driven by moisture, oxygen, and light. This presents a challenge for maintaining stability across supply-chain conditions and long shelf lives.
Intracellular Defense & IV-Alternatives
Non-Destructive Raman Spectroscopy for PAT-Based Botanical Contaminant Detection
Ensuring real-time quality control of botanical APIs is hindered by the need to detect trace contaminants, such as pesticide residues or adulterants, in heterogeneous botanical matrices while meeting regulatory sensitivity requirements.
Precision Microbiome & Gut-Brain Axis
Enteric Delivery of Butyrate: Overcoming Gastrointestinal Barriers for Vagal Activation
Free butyrate salts dissolve prematurely in the upper gastrointestinal tract, limiting their availability for distal gut signaling. Additionally, their pungent odor and taste present significant challenges for patient adherence in chronic applications.
No dossiers match the selected MeSH topic in this page. Try another tag or clear the filter.
Custom Formulation Available
Need a Dossier Built Around Your Molecule?
Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.